Literature DB >> 17065663

The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia.

Gerly M van der Vleuten1, Aaron Isaacs, Anneke Hijmans, Cornelia M van Duijn, Anton F H Stalenhoef, Jacqueline de Graaf.   

Abstract

Recently, the upstream stimulatory factor 1 gene (USF1) was proposed as a candidate gene for familial combined hyperlipidemia (FCH). In this study, we examined the previously identified risk haplotype of USF1 with respect to FCH and its related phenotypes in 36 Dutch FCH families. The diagnosis of FCH was based on both the traditional diagnostic criteria and a nomogram. The two polymorphisms, USF1s1 and USF1s2, were in complete linkage disequilibrium. No association was found for the individual single nucleotide polymorphisms (SNPs) with FCH defined by the nomogram (USF1s1, P = 0.53; USF1s2, P = 0.53), whereas suggestive associations were found when using the traditional diagnostic criteria for FCH (USF1s1, P = 0.08; USF1s2, P = 0.07). USF1 was associated with total cholesterol (USF1s1, P = 0.05; USF1s2, P = 0.04) and apolipoprotein B (USF1s1, P = 0.06; USF1s2, P = 0.04). Small dense LDL showed a suggestive association (USF1s1, P = 0.10; USF1s2, P = 0.09). The results from the haplotype analyses supported the results obtained for the individual SNPs. In conclusion, the previously identified risk haplotype of USF1 showed a suggestive association with FCH and contributed to the related lipid traits in our Dutch FCH families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065663     DOI: 10.1194/jlr.M600184-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

Review 1.  The genetics of familial combined hyperlipidaemia.

Authors:  Martijn C G J Brouwers; Marleen M J van Greevenbroek; Coen D A Stehouwer; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

2.  Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

Authors:  Thomas M van Himbergen; Seiko Otokozawa; Nirupa R Matthan; Ernst J Schaefer; Aaron Buchsbaum; Masumi Ai; Lambertus J H van Tits; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-15       Impact factor: 8.311

3.  A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.

Authors:  Christopher L Plaisier; Steve Horvath; Adriana Huertas-Vazquez; Ivette Cruz-Bautista; Miguel F Herrera; Teresa Tusie-Luna; Carlos Aguilar-Salinas; Päivi Pajukanta
Journal:  PLoS Genet       Date:  2009-09-11       Impact factor: 5.917

4.  Association analysis of allelic variants of USF1 in coronary atherosclerosis.

Authors:  Kati Kristiansson; Erkki Ilveskoski; Terho Lehtimäki; Leena Peltonen; Markus Perola; Pekka J Karhunen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

5.  USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study.

Authors:  K Auro; K Kristiansson; B Zethelius; C Berne; L Lannfelt; M-R Taskinen; M Jauhiainen; M Perola; L Peltonen; A-C Syvänen
Journal:  Diabetologia       Date:  2007-12-21       Impact factor: 10.122

6.  Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.

Authors:  Say-Hean Lye; Jagdish Kaur Chahil; Pramod Bagali; Livy Alex; Jamunarani Vadivelu; Wan Azman Wan Ahmad; Siew-Pheng Chan; Meow-Keong Thong; Shamsul Mohd Zain; Rosmawati Mohamed
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

7.  The Regulation of Cbf1 by PAS Kinase Is a Pivotal Control Point for Lipogenesis vs. Respiration in Saccharomyces cerevisiae.

Authors:  Desiree DeMille; Jenny A Pape; Benjamin T Bikman; Majid Ghassemian; Julianne H Grose
Journal:  G3 (Bethesda)       Date:  2019-01-09       Impact factor: 3.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.